| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
B Sites
Department of Preventive Medicine and AIDS Research, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan [N. M., N. Y.]; Department of Laboratory Medicine, Nagasaki University School of Medicine, Nagasaki 852-8501, Japan [Y. Yamad.]; Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine, Nagasaki 852-8523, Japan [M. T.]; Department of Internal Medicine, City of Sasebo General Hospital, Sasebo 857-8511, Japan [S. I.]; Department of Internal Medicine, Kokura Memorial Hospital, Kitakyushu 802-8555, Japan [Y. Yamas.]; Department of Pathology First Unit, Shimane Medical University, Izumo 693-8501, Japan [S. M.]; First Department of Internal Medicine, Yokohama City University School of Medicine, Yokohama 236-0004, Japan [A. U.]; Gladstone Institute of Virology and Immunology, San Francisco, California 94141-9100 [R. G.]; and Immunopathology Section, Laboratory of Immunobiology, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 [T. Y.]
Infection by human T-cell leukemia virus type (HTLV) I leads to adult
T-cell leukemia and is also associated with the
neurodegenerative disease HTLV-I-associated myelopathy/tropical spastic
paraparesis. Leukocytes are attracted to sites of inflammation by
chemokines. One such chemokine is monocyte chemoattractant protein
(MCP)-1, a member of the C-C subfamily of chemokines. We investigated
whether HTLV-I infection causes up-regulation of MCP-1, which may in
turn cause recruitment of leukocytes to HTLV-I-infected areas. We now
report that MCP-1 mRNA levels are elevated in HTLV-I-infected T-cell
lines, when compared with uninfected ones. We further confirmed
secretion of MCP-1 by HTLV-I-infected T-cell lines. MCP-1 mRNA was also
expressed in leukemic cells from patients with adult T-cell leukemia.
The 5' transcriptional regulatory region of the MCP-1
gene was activated by the HTLV-I-encoded transactivator Tax in
the human T-cell line Jurkat, in which endogenous MCP-1 is induced by
Tax. By using site-specific point mutations, we have identified two
closely spaced nuclear factor (NF)-
B sites, A1 and A2, to be
important for Tax-mediated transactivation of the MCP-1
gene. Through the use of an electrophoretic mobility shift assay, we
demonstrated that Tax induced NF-
B binding to both MCP-1
B sites.
This is the first report to demonstrate that Tax can transactivate the
MCP-1 gene through the induction of NF-
B. Our results
thus reveal how Tax disrupts the normally regulated
MCP-1 gene and leads to its constitutive expression in
HTLV-I-infected cells. These findings may have important implications
for our understanding of HTLV-I-associated diseases.
This article has been cited by other articles:
![]() |
K. Hieshima, D. Nagakubo, T. Nakayama, A.-K. Shirakawa, Z. Jin, and O. Yoshie Tax-Inducible Production of CC Chemokine Ligand 22 by Human T Cell Leukemia Virus Type 1 (HTLV-1)-Infected T Cells Promotes Preferential Transmission of HTLV-1 to CCR4-Expressing CD4+ T Cells J. Immunol., January 15, 2008; 180(2): 931 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Datta, U. Sinha-Datta, N. K. Dhillon, S. Buch, and C. Nicot The HTLV-I p30 Interferes with TLR4 Signaling and Modulates the Release of Pro- and Anti-inflammatory Cytokines from Human Macrophages J. Biol. Chem., August 18, 2006; 281(33): 23414 - 23424. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimauchi, S. Imai, R. Hino, and Y. Tokura Production of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine by CCR4+ Adult T-Cell Leukemia Cells Clin. Cancer Res., March 15, 2005; 11(6): 2427 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mori, Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, and M. Fujii Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells Blood, August 13, 2002; 100(5): 1828 - 1834. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |